HERBION NATURALS

Live / Registered — Registered (as of 03 Sept 2024)

What this means for you

Registered since 03 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97638096
Registration number
7496648
Mark type
Design + words
Filed
19 Oct 2022
Published for opposition
19 Sept 2023
Registered
03 Sept 2024

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inducing erections; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for reducing sexual activity; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in discouraging the smoking habit; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Alginates for pharmaceutical purposes; Almond milk for pharmaceutical purposes; Aloe vera preparations for pharmaceutical purposes; Aluminium acetate for pharmaceutical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Bicarbonate of soda for pharmaceutical purposes; Bismuth preparations for pharmaceutical purposes; Bismuth subnitrate for pharmaceutical purposes; Bromine for pharmaceutical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular pharmaceuticals; Caustics for pharmaceutical purposes; Creosote for pharmaceutical purposes; Cytostatics for pharmaceutical purposes; Dermatological pharmaceutical products; Dextrins for pharmaceutical use; Digestives for pharmaceutical purposes; Effervescent analgesic pharmaceutical preparations; Ethers for pharmaceutical purposes; Eucalyptus for pharmaceutical purposes; Extracts of hops for pharmaceutical purposes; Ferments for pharmaceutical purposes; Fish meal for pharmaceutical purposes; Flaxseed for pharmaceutical purposes; Flaxseed meal for pharmaceutical purposes; Frostbite salve for pharmaceutical purposes; Gardenia for pharmaceutical purposes; Guaiacol for pharmaceutical purposes; Hyaluronic acid for pharmaceutical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Iodine for pharmaceutical purposes; Linseed meal for pharmaceutical purposes; Liquorice for pharmaceutical purposes; Malt for pharmaceutical purposes; Meal for pharmaceutical purposes; Menthol for pharmaceutical purposes; Milk ferments for pharmaceutical purposes; Mint for pharmaceutical purposes; Ocular pharmaceuticals; Pepsins for pharmaceutical purposes; Phenol for pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Propolis for pharmaceutical purposes; Royal jelly for pharmaceutical purposes; Starch for pharmaceutical purposes; Stick liquorice for pharmaceutical purposes; Sunburn preparations for pharmaceutical purposes; Turpentine for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Veterinary pharmaceutical compounds for equine use to treat conditions of the leg, hoof, ear, nose and throat; Yeast extracts for medical, veterinary or pharmaceutical purposes; Yeast for pharmaceutical consumption; Yeast for pharmaceutical purposes; Yeast for medical, veterinary or pharmaceutical purposes; Yeast or yeast extracts for medical, veterinary or pharmaceutical purposes

Owner

Prosecution history

  • 03 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 03 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
  • 29 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 29 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 03 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 02 May 2024 — USE AMENDMENT FILED
  • 04 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 02 May 2024 — TEAS STATEMENT OF USE RECEIVED
  • 16 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 06 Mar 2024 — TTAB RELEASE CASE TO TRADEMARKS
  • 06 Mar 2024 — OPPOSITION TERMINATED NO. 999999
  • 06 Mar 2024 — OPPOSITION DISMISSED NO. 999999
  • 10 Oct 2023 — OPPOSITION INSTITUTED NO. 999999
  • 10 Oct 2023 — OPPOSITION PAPERS RECEIVED AT TTAB
  • 19 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View this trademark record on Marksy